• Search Research Projects
  • Search Researchers
  • How to Use
  1. Back to project page

2009 Fiscal Year Final Research Report

Establishment of new treatment strategy for advanced cancers : evaluation of the combination therapy of interventional radiology and chemotherapy

Research Project

  • PDF
Project/Area Number 18590670
Research Category

Grant-in-Aid for Scientific Research (C)

Allocation TypeSingle-year Grants
Section一般
Research Field Gastroenterology
Research InstitutionThe University of Tokyo

Principal Investigator

SHIINA Shuichirou  The University of Tokyo, 医学部附属病院, 講師 (70251238)

Co-Investigator(Kenkyū-buntansha) KATO Naoya  東京大学, 医学部附属病院, 助手 (90313220)
Project Period (FY) 2006 – 2009
Keywords進行癌 / IVR / 化学療法 / 大腸癌 / 肝転移
Research Abstract

Only chemotherapy was a treatment of choice for advanced cancers. Surgical resection is invasive and cannot be used for debulking purpose. This study was planned to evaluate the usefulness of the combination of interventional radiology and systemic chemotherapy and to establish a new treatment strategy for advanced cancers. At the initial plan, it was planned to compare the combination of radiofrequency ablation and systemic chemotherapy with systemic chemotherapy alone. However, it was difficult to randomly assign patients with advanced cancers into two groups : those treated by the combination of radiofrequency ablation and systemic chemotherapy and those by systemic chemotherapy alone. Thus, the randomized controlled trial was not performed.
In liver metastasis from colorectal cancer, that is the main subjects in this study, only 10 to 30% of the patients are said to be candidates for surgical resection. Furthermore, patients who already underwent hepatectomy or elderly patients ofte … More nrefuse surgery. At our department, we have performed a multimodal treatment using radiofrequency ablation as a main element. Indication of RFA with curative intent was ; 1) unresectable lesions or refusal of surgery, 2) lesion number〓5 & size〓5cm, 3) no extrahepatic lesions, and 4) no extensive contact with major vessels. Indication of RFA with debulking intent was ; 1) most lesions were in the liver, and 2) chemotherapy had not been performed or had been effective. We put no restrictions on lesion location. The subjects were 135 consecutive patients with liver metastasis from colorectal cancer on whom RFA was performed. There were 85 males and 50 females. The age was 64.8±11.1 (mean±S.D.) years. Twelve of them were 81 years old or older. Maximum lesion size was 3.2±1.3cm. Lesion number was 4.1±4.8. A total of 107 patients (79%) had received other treatment before RFA : 77 had received systemic chemotherapy, 38 hepatectomy, 22 intra-arterial chemotherapy, and so on (some patients had received multiple treatments). A total of 82 patients were not candidates for surgical resection, because 46 had unresectable extrahepatic lesions (29 unresectable lung metastases [three others had resectable lung metastasis], 13 lymph node metastases, 10 peritoneal seeding, 7 local recurrence at the primary site, and so on), 7 comorbid cardiopulmonary diseases, 20 unresectable multiple liver metastases, 4 unresectable multiple recurrences after hepatectomy, and 3 unresectable recurrence at the site of surgical margin after hepatectomy (some patients had plural conditions). After the therapy, CT scan from the chest to the pelvis and serum tumor marker levels were checked every 3 months. Systemic chemotherapy was generally recommended since the introduction of FOLFOX and FOLFIRI. However, some patients refused chemotherapy and others accepted only oral chemotherapy using S-1. Overall survival after RFA in 135 patients with liver metastasis from colorectal cancer was 91% at 1-year, 64% at 3-years, 36% at 5-years, and 27% at 7-years.
12 patients had already survived over 5 years and 6 patients over 7 years. Encountered complications were GI tract penetration in 3 cases, hepatic infarction in 3, liver abscess in 2 and others in 3. There was no mortality.
Overall survival after RFA in 16 patients with liver metastasis from gastric cancer was 74% at 1-year, 52% at 2-years, 43% at 3, 4, and 5-years. Two patients survived over 5 years.
Resection has been said to be the treatment of choice for metastatic liver tumors. However, the multimodal therapy using RFA as a main element achieved a high survival and not a small number of patients had survived more than 5 years, although many patients in this study had disadvantageous conditions. Treatment strategy to find recurrence at an early stage and to repeat minimally invasive therapies would be useful for metastatic liver tumors. The multimodal treatment using RFA as a main therapy should be among the treatments of choice for liver metastasis. Less

  • Research Products

    (10 results)

All 2009 2008 2007 2006

All Journal Article (5 results) Presentation (4 results) Book (1 results)

  • [Journal Article] ラジオ波焼灼術 (RFA) : 低侵襲治療の現状と今後の展開2009

    • Author(s)
      椎名秀一朗
    • Journal Title

      医学のあゆみ 231巻

      Pages: 187-188

  • [Journal Article] 転移性肝腫瘍に対するラジオ波焼灼術 (RFA)2009

    • Author(s)
      椎名秀一朗, 内野康志, 他(11番中1番目)
    • Journal Title

      臨床外科 64巻

      Pages: 1507-1514

  • [Journal Article] 進行癌症例に対する新治療戦略の確立-IVR・化学療法併用治療の評価2008

    • Author(s)
      椎名秀一朗
    • Journal Title

      がん治療のあゆみ

      Pages: 23-31

  • [Journal Article] 転移性肝癌に対する経皮的ラジオ波焼灼術 (RFA)2007

    • Author(s)
      椎名秀一朗
    • Journal Title

      消化器科 45巻

      Pages: 108-113

  • [Journal Article] 転移性肝癌2006

    • Author(s)
      椎名秀一朗
    • Journal Title

      内科 97巻

      Pages: 1034-1035

  • [Presentation] 大腸癌肝転移に対するラジオ波焼灼術 (RFA) を中心とした集学的治療2009

    • Author(s)
      椎名秀一朗
    • Organizer
      第51回日本消化器病学会
    • Place of Presentation
      京都
    • Year and Date
      2009-10-16
  • [Presentation] PD2 大腸癌肝転移に対するラジオ波焼灼術 (RFA)2008

    • Author(s)
      椎名秀一朗
    • Organizer
      DDW JAPAN
    • Place of Presentation
      東京
    • Year and Date
      2008-10-01
  • [Presentation] WS1 進行消化器癌に対する経皮的ラジオ波焼灼術 (RFA) を中心とした集学的治療の成績2008

    • Author(s)
      椎名秀一朗
    • Organizer
      第94回日本消化器病学会
    • Place of Presentation
      福岡
    • Year and Date
      2008-05-10
  • [Presentation] PD11 転移性肝がんの治療戦略 転移性肝腫瘍に対する経皮的ラジオ波焼灼術 (RFA)2006

    • Author(s)
      椎名秀一朗
    • Organizer
      DDW Japan
    • Place of Presentation
      札幌
    • Year and Date
      2006-10-13
  • [Book] 動画で学ぶ肝癌ラジオ波焼灼療法の実際2009

    • Author(s)
      椎名秀一朗
    • Total Pages
      35
    • Publisher
      医学書院

URL: 

Published: 2011-06-18   Modified: 2016-04-21  

Information User Guide FAQ News Terms of Use Attribution of KAKENHI

Powered by NII kakenhi